Clinical trial
A Phase II Randomised, Double Blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of CT327 Topical Ointment (0.05% and 0.5% w/w) Compared to Vehicle, in Subjects With Mild or Moderate Atopic Dermatitis and at Least Moderate Pruritus
NCT01808157 is registered in ClinicalTrials.gov with Creabilis SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Randomised, Double Blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of CT327 Topical Ointment (0.05% and 0.5% w/w) Compared to Vehicle, in Subjects With Mild or Moderate Atopic Dermatitis and at Least Moderate Pruritus
- Lead sponsor
- Creabilis SA
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- April 30, 2014
- Enrollment
- 188 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis